These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

851 related items for PubMed ID: 23800497

  • 1. The impact of intracranial carotid artery calcification on the development of thrombolysis-induced intracerebral hemorrhage.
    Lin TC, Chao TH, Shieh Y, Lee TH, Chang YJ, Lee JD, Peng TI, Chang KC, Liou CW, Chang TY, Hung KL, Chang CH.
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e455-62. PubMed ID: 23800497
    [Abstract] [Full Text] [Related]

  • 2. The iScore predicts efficacy and risk of bleeding in the National Institute of Neurological disorders and Stroke Tissue Plasminogen Activator Stroke Trial.
    Saposnik G, Demchuk A, Tu JV, Johnston SC, Stroke Outcomes Research Canada (SORCan) Working Group.
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):876-82. PubMed ID: 23102741
    [Abstract] [Full Text] [Related]

  • 3. Blood pressure variability after intravenous thrombolysis in acute stroke does not predict intracerebral hemorrhage but poor outcome.
    Kellert L, Sykora M, Gumbinger C, Herrmann O, Ringleb PA.
    Cerebrovasc Dis; 2012 Aug; 33(2):135-40. PubMed ID: 22179586
    [Abstract] [Full Text] [Related]

  • 4. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC, Gupta R, Smith WS, Kamel H, Faigeles BS, Cullen SP, Rao VA, Bath PM, Wahlgren N, Ahmed N, Donnan GA, SITS International and VISTA-plus investigators.
    Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
    [Abstract] [Full Text] [Related]

  • 5. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
    Roveri L, La Gioia S, Ghidinelli C, Anzalone N, De Filippis C, Comi G.
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
    [Abstract] [Full Text] [Related]

  • 6. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A, Epstein D, Cohen D, Bathula R, Devine J, Kar A, Taube D, Duncan N, Ames D.
    Cerebrovasc Dis; 2013 Aug; 35(1):45-52. PubMed ID: 23428996
    [Abstract] [Full Text] [Related]

  • 7. Modest association between the discharge modified Rankin Scale score and symptomatic intracerebral hemorrhage after intravenous thrombolysis.
    Asuzu D, Nystrom K, Amin H, Schindler J, Wira C, Greer D, Chi NF, Halliday J, Sheth KN.
    J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):548-53. PubMed ID: 25540072
    [Abstract] [Full Text] [Related]

  • 8. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
    Anaissie JE, Monlezun DJ, Siegler JE, Waring ED, Dowell LN, Samai AA, George AJ, Kimbrough T, Berthaud J, Martin-Schild S.
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2603-2609. PubMed ID: 27476340
    [Abstract] [Full Text] [Related]

  • 9. Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study.
    Paciaroni M, Agnelli G, Caso V, Pieroni A, Bovi P, Cappellari M, Zini A, Nichelli P, Inzitari D, Nesi M, Nencini P, Pezzini A, Padovani A, Tassinari T, Orlandi G, Chiti A, Gialdini G, Alberti A, Venti M, Acciarresi M, D'Amore C, Luda E, Tassi R, Martini G, Ferrarese C, Beretta S, Trentini C, Silvestrelli G, Lanari A, Previdi P, Ciccone A, Delodovici ML, Bono G, Galletti G, Marcheselli S, Del Sette M, Traverso E, Riva M, Silvestrini M, Cerqua R, Consoli D, Monaco S, Toni D.
    Cerebrovasc Dis; 2012 Nov; 34(5-6):430-5. PubMed ID: 23207482
    [Abstract] [Full Text] [Related]

  • 10. Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?
    Hassan AE, Chaudhry SA, Jani V, Grigoryan M, Khan AA, Adil MM, Qureshi AI.
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):545-9. PubMed ID: 23453555
    [Abstract] [Full Text] [Related]

  • 11. Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR.
    Toni D, Ahmed N, Anzini A, Lorenzano S, Brozman M, Kaste M, Mikulik R, Putaala J, Wahlgren N, SITS investigators.
    Neurology; 2012 Mar 20; 78(12):880-7. PubMed ID: 22402853
    [Abstract] [Full Text] [Related]

  • 12. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
    Mori M, Naganuma M, Okada Y, Hasegawa Y, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Kario K, Okuda S, Koga M, Minematsu K, Toyoda K.
    Cerebrovasc Dis; 2012 Mar 20; 34(2):140-6. PubMed ID: 22854333
    [Abstract] [Full Text] [Related]

  • 13. Intracranial Internal Carotid Artery Wall Calcification in Ischemic Strokes Treated with Thrombolysis.
    Tábuas-Pereira M, Sargento-Freitas J, Silva F, Parra J, Mendes P, Seara V, Mesquita M, Baptista M, Cordeiro G, Cunha L.
    Eur Neurol; 2018 Mar 20; 79(1-2):21-26. PubMed ID: 29131095
    [Abstract] [Full Text] [Related]

  • 14. Stroke outcomes of Japanese patients with major cerebral artery occlusion in the post-alteplase, pre-MERCI era.
    Endo K, Koga M, Sakai N, Yamagami H, Furui E, Matsumoto Y, Shiokawa Y, Yoshimura S, Okada Y, Nakagawara J, Hyogo T, Hasegawa Y, Nagashima H, Fujinaka T, Hyodo A, Terada T, Toyoda K, Joint Research Group from JR-NET2 and SAMURAI Study Investigators.
    J Stroke Cerebrovasc Dis; 2013 Aug 20; 22(6):805-10. PubMed ID: 22721823
    [Abstract] [Full Text] [Related]

  • 15. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S, Deguchi K, Morimoto N, Kurata T, Deguchi S, Yamashita T, Ikeda Y, Matsuura T, Narai H, Omori N, Manabe Y, Yunoki T, Takao Y, Kawata S, Kashihara K, Abe K.
    J Stroke Cerebrovasc Dis; 2013 Apr 20; 22(3):190-6. PubMed ID: 21968092
    [Abstract] [Full Text] [Related]

  • 16. Low Alberta stroke program early computed tomography score within 3 hours of onset predicts subsequent symptomatic intracranial hemorrhage in patients treated with 0.6 mg/kg Alteplase.
    Hirano T, Sasaki M, Tomura N, Ito Y, Kobayashi S, Japan Alteplase Clinical Trial Group.
    J Stroke Cerebrovasc Dis; 2012 Nov 20; 21(8):898-902. PubMed ID: 21737309
    [Abstract] [Full Text] [Related]

  • 17. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
    Pundik S, McWilliams-Dunnigan L, Blackham KL, Kirchner HL, Sundararajan S, Sunshine JL, Tarr RW, Selman WR, Landis DM, Suarez JI.
    J Stroke Cerebrovasc Dis; 2008 Sep 20; 17(5):266-72. PubMed ID: 18755405
    [Abstract] [Full Text] [Related]

  • 18. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
    Ong CT, Wong YS, Wu CS, Su YH.
    Drug Des Devel Ther; 2017 Sep 20; 11():1559-1566. PubMed ID: 28572721
    [Abstract] [Full Text] [Related]

  • 19. Intravenous Thrombolysis for Acute Ischemic Stroke due to Cervical Internal Carotid Artery Occlusion.
    Yeo LL, Kong WY, Paliwal P, Teoh HL, Seet RC, Soon D, Rathakrishnan R, Ong V, Lee TH, Wong HF, Chan BP, Leow WK, Yuan C, Ting E, Gopinathan A, Tan BY, Sharma VK.
    J Stroke Cerebrovasc Dis; 2016 Oct 20; 25(10):2423-9. PubMed ID: 27344361
    [Abstract] [Full Text] [Related]

  • 20. Atherosclerotic intracranial internal carotid artery calcification and intravenous thrombolytic therapy for acute ischemic stroke.
    Gocmen R, Arsava EM, Oguz KK, Topcuoglu MA.
    Atherosclerosis; 2018 Mar 20; 270():89-94. PubMed ID: 29407893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.